Giving patients who have septic shock a combo of two steroids could potentially be a lifesaver, according to a new study. Researchers found that patients receiving a combination of hydrocortisone and fludrocortisone had lower death rates and discharge to hospice compared to those who received hydrocortisone alone. “Our results provide robust evidence that one steroid regimen is superior to the other regimen and, in absence of further clinical trials, directly inform the choice of steroids in patients with septic shock,” said study co-author Dr. Nicholas Bosch, an assistant professor at Boston University’s Chobanian & Avedisian School of Medicine. For the study, published March 27 in JAMA Internal Medicine, researchers compared treatment options using a multicenter database that included about 25% of U.S. hospitalizations. The study was designed to mimic a randomized clinical trial. The team compared the outcome of death or discharge to hospice between patients who received the regimen of hydrocortisone and fludrocortisone to those who received hydrocortisone alone. On average, patients who received the combined regimen died or were discharged to hospice about 4% less of the time than patients who received hydrocortisone alone. More than a third of the estimated 1.7 million U.S. hospitalizations involving sepsis — an extreme response to infection — each year end in death. These findings may change clinical practice, the authors said. “It is possible that guideline…  read on >  read on >

If you’re one of the millions of people with allergic asthma or eczema, you may be more likely to develop the wear-and-tear form of arthritis as you age. This is the main finding from a new study that examined the risk of developing osteoarthritis among people with the two allergic conditions. The study wasn’t designed to say how, or even if, these allergic diseases increase osteoarthritis risk, but the researchers do have a theory. “Our group has done work showing that mast cells [a type of allergic cell] are increased in numbers in the joints of people with osteoarthritis, and their activity contributes to the development of osteoarthritis,” said study author Dr. Matthew Baker, clinical chief in the division of immunology and rheumatology at Stanford University in Stanford, Calif. And asthma and eczema may be the tip of the iceberg, he said. “It is possible that other atopic conditions such as seasonal allergies, food allergies and/or allergic rhinitis [hay fever] may provide a similar risk,” Baker noted. These researchers did not look at these conditions in the new study. For the study, they reviewed insurance claims from two databases. The first set included more than 117,000 people with asthma or eczema and 1.2 million people without these conditions. After eight years of follow-up, the risk of developing osteoarthritis was 58% higher among folks with allergic…  read on >  read on >

Researchers have discovered that two drugs might be better than one for women who have advanced endometrial cancer. Combining chemotherapy and immunotherapy or a monoclonal antibody at the same time helped these patients live longer without their cancer progressing, especially those who had a specific type of endometrial cancer known as a mismatch repair-deficient tumor. “We found a profound improvement,” Dr. Carol Aghajanian, a medical oncologist specializing in gynecologic cancers at Memorial Sloan Kettering Cancer Center in New York City, who was senior study author on one of the reports, told NBC News. The findings from the two studies were published March 27 in the New England Journal of Medicine and simultaneously presented at the annual meeting of the Society of Gynecologic Oncology in Tampa, Fla. “This is going to drastically change the conversation” with patients — “probably as of tomorrow,” Dr. David O’Malley, a gynecologic oncologist with The Ohio State University Comprehensive Cancer Center, told NBC News. Chemotherapy is typically used to treat women with this cancer, and immunotherapy is only approved as a second-line treatment. But in one study, researchers led by Aghajanian found that adding the immunotherapy drug pembrolizumab (Keytruda) to a standard chemotherapy regimen of carboplatin and paclitaxel cut the risk of disease progression or death in patients by up to 70%. The improvement was an average of 13.1 months before…  read on >  read on >

Children with mental health problems are flooding America’s hospitals. A new study of 4.8 million pediatric hospitalizations between 2009 and 2019 found that the number of acute care hospitalizations for kids with mental health problems increased significantly. In 2019, most were due to attempted suicides, suicidal thoughts or self-injury, researchers said. “What we’re seeing are more and more hospital stays by children and adolescents due to mental health concerns in terms of absolute numbers, and a substantially larger fraction of these stays are related to suicide or self-injury,” said study leader Mary Arakelyan, research project manager at Dartmouth-Hitchcock Medical Center in Lebanon, N.H. “With hospitalizations for mental health concerns representing a larger proportion of all pediatric hospitalizations in 2019 than in 2009, it’s imperative to consider how inpatient settings will meet the mental health needs of a growing population of young people,” she added. The study found that pediatric mental health hospitalizations rose 26% between 2009 and 2019. And, over that same period, those owing to attempted suicide, suicidal thought or self-injury increased from 31% to 64%. Senior researcher Dr. JoAnna Leyenaar, vice chair of research in the pediatric department at Dartmouth-Hitchcock, said kids with mental health issues go to hospitals because they have nowhere else to turn. “Acute care hospitals provide access to care for youth and families when they’re experiencing a mental health…  read on >  read on >

Could inhaling a deep whiff of another person’s sweat help ease crippling social anxiety? Quite possibly, new Swedish research suggests. The notion stems from a trial that involved just 48 women. All struggled with what’s known as social anxiety disorder — an often intense and relentless fear of being watched or judged by others when participating in common social situations. The standard course of treatment centers on talk therapy involving meditation practices that are designed to ease some of the anxiety that arises. But Swedish researchers discovered that when such “mindfulness therapy” is combined with the inhaling of sweat of others, the result appears to be a far steeper drop in anxiety levels. “Social anxiety is a common disorder which entails an intense and persistent fear of social situations,” explained study author Elisa Vigna, a research assistant with the Swedish National Centre for Suicide Research and Prevention at the Karolinska Institute. “This can lead to anxiety and fear of common situations like speaking in front of an audience, meeting new people, even talking to a cashier in a store. So, it can be very debilitating, affecting many areas of everyday life.” This is the first study that uses body odor as a treatment enhancer, Vigna noted. The results “were very interesting and promising,” she said. While a single session of mindfulness therapy alone triggered a…  read on >  read on >